Oren Ilan 4

What Happened
Oren Ilan, a non-employee director of Roivant Sciences Ltd. (ROIV), was granted 775 common shares on 2026-07-17 as an award under the Issuer's Non-Employee Director Compensation Plan. The filing reports an acquisition type "A" with an acquisition price of $0.00 (the award was fully vested as of the grant date), so the transaction shows no cash outlay by Ilan.

Key Details

• Transaction date: 2026-07-17 (Form 4 filed 2026-07-21). Filing appears timely.
• Transaction type/code: Award/Grant (A).
• Shares acquired: 775 common shares at $0.00 per share (reported value $0).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 — award received pursuant to the Issuer's Non-Employee Director Compensation Plan and was fully vested as of the grant date.
• Remarks: Exhibit 24 — Power of Attorney included.

Context
This is a routine director compensation award for a non-employee director, not a market purchase or sale. Such vested share grants are common as part of board pay and do not necessarily indicate insider buying or selling sentiment.